M33 Growth, a Boston-based venture firm, announced a partnership with U.S. Neurology Associates (USNA), a physician services organization focused on community-based neurology care. Nitin Jain will serve as CEO and Brad Hively as Chairman. USNA aims to provide comprehensive, integrated neurological care including in-office infusions, diagnostics, and clinical trials while reducing operational burdens on physicians and delivering cost-effective solutions to patients and payers.

The Oncology Institute promoted Rakesh Panda to Chief Information Officer and Nolan Mariano to Chief People Officer. Panda brings 25+ years of IT and digital transformation experience from roles at Cisco and Infosys, while Mariano brings 18 years of People Operations experience. The promotions support TOI's growth in value-based cancer care and technology-enabled care delivery.

The Oncology Institute (TOI) has seen a massive stock rally of over 950% in 2025, driven by its value-based cancer care approach, AI-driven operational efficiencies, and potential for growth across multiple states.

The Oncology Institute reported Q2 2025 revenue of $119.8 million, a 21.5% year-over-year increase, driven by strong pharmacy segment performance. Despite revenue growth, the company continues to face challenges with net losses and cash burn.

The Oncology Institute, Inc. (TOI) announced a $16.5 million private placement with existing investors, management, and directors. The proceeds will be used for organic growth and working capital. The company also entered an exchange agreement with Deerfield Management Company to exchange convertible notes for preferred stock and warrants.

Grapevine, a healthcare supply chain innovation company, has helped The Oncology Institute (TOI) achieve over $1.7 million in medical supply savings year to date. Grapevine's digital procurement platform has enabled TOI to diversify its supply chain, increase competition among suppliers, and significantly reduce patient care costs.

The Oncology Institute, LLC (TOI) announced that it will release its third quarter 2024 financial results on November 13, 2024, followed by a conference call. TOI is a value-based oncology group in the United States.

The Oncology Institute, Inc. (TOI) is expanding into Oregon with the opening of two new specialty cancer clinics in Portland and Salem. The new clinics will offer cutting-edge cancer care services and are part of TOI's commitment to value-based care and providing advanced treatment options to the community.

The Oncology Institute (TOI) delivered earnings and revenue surprises of -83.33% and 0.53%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Viatris (VTRS) delivered earnings and revenue surprises of -1.47% and 2.12%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

TORONTO, May 08, 2024 (GLOBE NEWSWIRE) -- Topicus.com Inc. (TSXV: TOI) today announced that Robin van Poelje has assumed the role of Chairman & CEO of Your.World on a part-time basis, to be made effective as of today, which role will be in addition to his current role as Chairman & CEO of Topicus.com.

TORONTO, May 01, 2024 (GLOBE NEWSWIRE) -- Topicus.com Inc. (TSXV:TOI) in a joint release with Constellation Software Inc. (TSX:CSU) today announced financial results for Topicus.com Inc. (“Topicus” or the “Company”) for the first quarter ended March 31, 2024. Please note that all amounts referred to in this press release are in Euros unless otherwise stated.